Aequim Alternative Investments LP - Q2 2019 holdings

$354 Million is the total value of Aequim Alternative Investments LP's 47 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .

 Value Shares↓ Weighting
CATM ExitCARDTRONICS PLC$0-3,800
-100.0%
-0.05%
ExitZILLOW GROUP INCnote 1.500% 7/0$0-3,000,000
-100.0%
-0.98%
ARRY ExitARRAY BIOPHARMA INC$0-165,000
-100.0%
-1.44%
ENRPRA ExitENERGIZER HLDGS INC NEW7.5 mcnv pfd a$0-50,000
-100.0%
-1.74%
ExitINTEGRATED DEVICE TECHNOLOGYnote 0.875%11/1$0-13,500,000
-100.0%
-7.58%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2019-11-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NICE SYS INC19Q3 20236.3%
BIOMARIN PHARMACEUTICAL INC18Q3 20230.8%
EURONET WORLDWIDE ORD18Q3 20230.4%
CLEVELAND CLIFFS ORD17Q3 20231.9%
AIR TRANSPORT SERVICES GRP I17Q1 20230.5%
LIBERTY MEDIA CORP DELAWARE16Q3 20235.6%
ECHOSTAR CORP16Q3 20230.9%
BAUSCH HEALTH COS INC15Q1 20230.3%
O-I GLASS INC15Q3 20230.2%
JAZZ PHARMACEUTICALS PLC14Q3 20230.1%

View Aequim Alternative Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-13
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-15
13F-HR2023-08-10
13F-HR2023-05-12
13F-HR2023-02-14
SC 13G2023-01-10
13F-HR2022-11-14
13F-HR2022-08-15

View Aequim Alternative Investments LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Aequim Alternative Investments LP's holdings